Health News
Mental Health Meds and Driving Risks
Medications prescribed for common mental health conditions can be incredibly important treatment options. However, they come with risks as well.
FDA Drug Safety Communication: Methylene blue (UPDATE)
The U.S. Food and Drug Administration (FDA) has received reports of serious central nervous system (CNS) reactions when the drug methylene blue is given to patients taking psychiatric medications that work through the serotonin system of the brain ( serotonergic psychiatric medications).
Stimulating Effects
Deep brain stimulation has proven beneficial for some treatment-resistant cases of obsessive-compulsive disorder (OCD), depressive disorders and Tourette syndrome.